Tresiba® for type 1 diabetes Tresiba® for type 1 diabetes Tresiba® for type 1 diabetes

HOW TRESIBA® WORKS

A slow and steady release that works the way your body’s insulin does

Once-daily injection
Tresiba® comes in FlexTouch® and is taken by injection. Once injected, Tresiba® helps the sugar in your blood get into your cells. Sugar provides your cells with energy needed to fuel your body.

Unique molecular design
The unique molecular design of Tresiba® allows it to connect like a string of pearls.

Around-the-clock control
Tresiba® releases slow and steady from the ends of the chain for around-the-clock blood sugar control. 

Clinical studies have shown that Tresiba® delivers

Tresiba® has been studied in multiple clinical trials in adults with type 2 and type 1 diabetes. These studies have examined Tresiba® in the following ways:

Tresiba® vs Lantus® in type 2 diabetes.

You can take once-daily Tresiba® at any time of day, and still stay in control. If you miss or delay a dose, take Tresiba® as soon as you remember, then continue with your regular dosing schedule. Make sure there are at least 8 hours between doses.

Tresiba® U-200 FlexTouch® doses up to 160 units in a single injection.

Tresiba® vs Lantus® in type 1 diabetes.

Tresiba® vs Lantus® in type 2 diabetes.

Compared with Lantus® in type 2 diabetes

Was Tresiba® studied vs Lantus® in adults with type 2 diabetes?

Yes!

Several studies compared Tresiba® vs Lantus® (insulin glargine U-100) in adults with type 2 diabetes.

The studies showed that when administered once a day, Tresiba® and Lantus® provided similar blood sugar control. No clinically important differences in risk of hypoglycemia (low blood sugar) between Tresiba® and comparators were observed in clinical trials.

Key study details:

  • Patients had type 2 diabetes
  • Included patients new to insulin or previously on insulin
  • The groups were randomized
  • The studies were either 26 or 52 weeks
  • The trials were open-label 
You can take once-daily Tresiba® at any time of day, and still stay in control. If you miss or delay a dose, take Tresiba® as soon as you remember, then continue with your regular dosing schedule. Make sure there are at least 8 hours between doses.

With changing schedules

Will Tresiba® let me adjust my daily dose time if needed and still keep my blood sugar under control?

Yes!

A study evaluated whether administering Tresiba® at varied daily dose times provided the same blood sugar control compared with using Lantus® (insulin glargine U-100) or Tresiba® once daily at the same time each day.

This study showed that adults with type 2 diabetes can vary their daily dosing time of Tresiba® by 8 to 40 hours without compromising blood sugar control. Taking Tresiba® at various daily dose times provided similar control to taking Lantus® or Tresiba® at the same time every day.

If you miss or delay a dose, take Tresiba® as soon as you remember, making sure there are at least 8 hours between doses.

Key study details:

  • Patients had type 2 diabetes
  • Patients took the insulin in combination with up to 3 diabetes pills
  • Included patients new to insulin or previously on insulin
  • The groups were randomized
  • The study was for 26 weeks
  • The trial was open-label
Tresiba® U-200 FlexTouch® doses up to 160 units in a single injection.

In a 160-unit maximum-dose pen

Can I keep my blood sugar under control in 1 injection per day, even if I need more than 80 units?

Yes!

One study compared Tresiba® U-200 vs Lantus® (insulin glargine U-100) to see if the concentration of Tresiba® U-200 allowed adults with type 2 diabetes to get similar blood sugar control from half the volume of the competing insulin.

The study showed that Tresiba® U-200 worked as well as Lantus®. This means Tresiba® U-200 can be as effective at lowering blood sugar. Tresiba® U-200 FlexTouch® is a 160-unit maximum-dose pen, and Lantus® SoloSTAR® is an 80-unit maximum-dose pen. So patients can dose up to 160 units in a single injection with Tresiba® U-200, which could mean fewer daily injections.

Key study details:

  • Patients had type 2 diabetes
  • Patients took the insulin in combination with metformin with or without a dipeptidyl peptidase-4 (DPP-4) inhibitor
  • Only included patients new to insulin
  • The groups were randomized
  • The study was for 26 weeks
  • The trial was open-label
Tresiba® vs Lantus® in type 1 diabetes.

Compared with Lantus® in type 1 diabetes

Does Tresiba® work similarly to Lantus® for adults with type 1 diabetes?

Yes!

One study compared Tresiba® vs Lantus® (insulin glargine U-100) in adults with type 1 diabetes.

This study showed that when administered once a day, along with fast-acting insulin at mealtimes, Tresiba® and Lantus® provided similar blood sugar control.

Key study details:

  • Patients had type 1 diabetes
  • The groups were randomized
  • The study was for 52 weeks
  • The trial was open-label
Words to know

Randomized

People are randomly assigned to one of the different groups being studied.

Open-label trial

Both the researchers and the participants know which treatment is being used.

Questions for your doctor

We’ve prepared some questions to help guide the conversation with your health care provider.

Get the guide 

Is insulin right for me?

Read about insulin, how it works, and how it affects blood sugar, so that you can better understand how it can help manage your diabetes as part of an overall treatment plan.

Learn more